Clinical Trials Browser

Not yet recruiting × Triple Negative Breast Neoplasms × Docetaxel × Clear all

NCT06795503 2025-01-28

Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients

Phase 3 Not yet recruiting

Triple Negative Breast Neoplasms